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Abstract 
Purpose: To investigated the effect of hemin, a heme oxygenase-1 (HO-1) inducer, on nicotinamide 
adenine dinucleotide phosphate oxidase (NOX) expression in rats with alcohol-induced liver injury.  
Methods: Male Wistar rats were randomly divided into four groups consisting of the control group, the 
ethanol (EtOH) group, the EtOH + zinc protoporphyrin IX (ZnPP-IX) group and EtOH + hemin group. 
Hepatic NOX gene expression and immunohistochemistry of hepatic NOX1 and NOX4 were 
investigated in week 4.  
Results: EtOH significantly increased levels of NOX. An immunohistochemical study demonstrated a 
high number of immunopositive hepatocytes for NOX1 in the EtOH group and EtOH + ZnPP-IX group 
compared with the control group. Hemin administration downregulated NOX gene expression and 
lowered the number of immunopositive hepatocytes for NOX1. In contrast, ZnPP-IX (HO-1 inhibitor) 
administration caused upregulation of NOX gene expression and increased the number of 
immunopositive hepatocytes for NOX1.  
Conclusion:  HO-1 inducer, hemin, alleviates oxidative stress-induced alcoholic liver injury by reducing 
NOX, especially NOX1. 
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Alcohol-induced liver disease is an increasing 
global health problem. Acute alcohol 
consumption leads to fatty liver. Although fatty 
liver is a reversible injury, its progression can 
develop into more severe liver problems 
including steatohepatitis and cirrhosis [1]. 
Previous studies showed that oxidative stress is 
an important factor contributing to the 
development of alcohol-induced liver injury [2]. 
Ethanol consumption has been shown to 
increase the production of reactive oxygen 
species (ROS)/reactive nitrogen species (RNS), 
decrease cellular antioxidant levels, and 
eventually enhance oxidative stress in many 
tissues, especially the liver [3]. ROS/RNS play 
the critical roles in damage to several 
macromolecules especially lipids, proteins and 
DNA, eventually causing alcohol-induced liver 
disease [4]. 
 
ROS mainly comprise superoxide radical (O2•-), 
hydroxyl radical (•OH), hydrogen peroxide 
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(H2O2). A variety of stimuli can produce O2•- 
through nicotinamide adenine dinucleotide 
phosphate oxidase (NOX) [5]. NOX1 and NOX4 
are expressed in liver; NOX1 mainly produces 
O2•- whereas NOX4 directly produces H2O2 [6]. 
NOX1 bind with their structural subunits to form 
active complexes associated with p22phox, 
p47phox, p67phox, and active Rac. NOX4 is a 
constitutively active membrane-bound isoform 
associated with p22phox only [7].  Oxidative 
stress can cause increased expression of heme 
oxygenase-1 (HO-1) levels [8]. Recently, 
Palipoch et al. demonstrated that HO-1 inducer 
hemin can relieve alcohol-induced liver injury, 
especially hepatic steatosis [9]. However, the 
underlying mechanisms of hemin remain unclear. 
Accordingly, this study aims to investigate the 
effect of HO-1 inducer hemin on NADPH oxidase 







Male Wistar rat strains (n=24) (Rattus 
norvegicus) 12 weeks of age were purchased 
from the Division of Animal House, Faculty of 
Science, Prince of Songkla University, Thailand. 
Animal procedures were performed with the 
approval of the Animal Ethics Committee, 
Walailak University (protocol no. 003/2014) and 
followed the Guide for the Care and Use of 
Laboratory Animals, National Research Council 
[10]. The animals were provided free access to 
standard commercial rat diet and distilled water 
before the experiment.  
 
Rats were randomly divided into four groups (n = 
6 per group): 1) rats gavaged with normal saline 
(control group); 2) rats gavaged with ethanol (30 
% v/v in saline, 5 g/kg) once a day for 4 weeks 
(the EtOH group); 3) rats gavaged with ethanol 
and intraperitoneally (i.p.) injected with zinc 
protoporphyrin IX (ZnPP-IX) (20 µmol/kg), a HO-
1 inhibitor, every week for 4 weeks (the EtOH + 
ZnPP-IX group); and 4) rats gavaged with 
ethanol and i.p. injected with hemin (30 µmol/kg), 
a HO-1 inducer, every week for 4 weeks (the 
EtOH + hemin group). Alcohol feeding was 
performed according to the procedure of Nan et 
al. [11]. In weeks 4, the rats were euthanized 
with an anesthetizing thiopental sodium overdose 
(100 mg/kg BW). The abdominal cavity was then 
opened, and the liver was collected. 
 
Hepatic NOX gene expression by RT-PCR  
 
Hepatic total RNA was extracted using an 
RNeasy Mini Kit (Qiagen, Germany). The content 
and purity of RNA were measured using a UV 
spectrophotometer. Reverse transcription-
polymerase chain reaction (RT-PCR) was 
performed for amplification of the NOX gene. The 
thermal cycling conditions were set up with an 
initial denaturation step at 95 °C for 15 min and 
at 94 °C for 1 min. The second step included an 
annealing of primer at 65 °C for 1 min and the 
third step comprised an extension at 72 °C for 1 
min. The final step comprised an elongation at 72 
°C for 10 min. The NOX primers were 5′-
GGAAATAGAAAGTT GACTGGCCC-3′, forward, 
and 5′-GTATGAGTGCCATCCAGAGCAG-3′, 
reverse [12], and the beta actin primers were 5′-
TTCTTTGCAGCTCCTTCGTTGCCG-3′, forward, 
and 5′-TGGATGGCT ACGTACATGG CTGGG-
3′, reverse [13]. The DNA samples were loaded 
into 2 % gel agarose. When stained with 
ethidium bromide, the gel was visualized with an 
UV transilluminator. The amount of PCR product 
was detected using the GeneTools software with 
image analysis (Syngene, Frederick, MD, USA). 
 
Immunohistochemistry of hepatic NOX1 and 
NOX4 
 
The liver sections were de-paraffinized and 
rehydrated. Heat-induced epitope retrieval was 
performed in sodium citrate buffer solution, pH 
6.0 (Vector Laboratories, CA, USA), using a 
microwave. Endogenous peroxidase activity was 
quenched in 3 % hydrogen peroxide in distilled 
water. Subsequently, the sections were 
incubated with the blocking buffer (normal goat 
serum) at room temperature for 30 min for 
blocking nonspecific binding site. After draining 
off the blocking buffer, the liver sections were 
incubated with optimal primary antibody 
containing rabbit anti-mouse NOX1 (Santa Cruz 
Biotechnology Inc., USA) and rabbit anti-mouse 
NOX4 (Santa Cruz Biotechnology Inc., USA) in a 
humidified chamber at 4 °C overnight.  
 
After washing them three times with phosphate-
buffered saline (PBS), the sections were 
incubated with appropriately diluted secondary 
antibody (Santa Cruz Biotechnology Inc., USA) in 
a humidified chamber at room temperature for 30 
min. After washing with PBS, avidin-biotin 
complex (ABC) conjugated with horseradish 
peroxidase (HRP) (Vectastain ABC Kit, USA) 
was added to the sections. Subsequently, the 
sections were washed with PBS, and then the 
DAB Kit (Vector Laboratories, USA) was applied 
for 3 min. After counterstaining with Mayer’s 
hematoxylin (Merck, Darmstadt, Germany), the 
liver sections were dehydrated and mounted [14] 
and semi-quantitatively examined under a light 
microscope. All slides were randomly evaluated 
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in 50 microscopic fields at high magnification by 




Statistical analysis was performed using IBM 
SPSS statistics (version 23). All data are 
presented as mean ± standard error of the mean 
(SEM). Comparison between groups were 
performed using one-way analysis of variance 
(ANOVA). Post hoc comparison was performed 
using least significant difference (LSD) test. 




HO-1 inducer hemin reduced NOX mRNA 
levels in ethanol - treated rats 
 
The rats treated with ethanol (the EtOH group) 
and the rats treated with ethanol and injected 
with zinc protoporphyrin IX (the EtOH + ZnPP-IX 
group) had significantly enhanced (p < 0.05) 
NOX mRNA levels in the liver compared with rats 
in the control group, as shown in Figure 1. The 
rats treated with hemin had statistically 
significantly reduced (p < 0.001) NOX mRNA 
levels compared with rats in the EtOH group and 
the EtOH + ZnPP-IX group. 
 
  
Figure 1: Hepatic NOX mRNA levels at week 4 (per 
group n = 6). a, b, c Compared with the control group, 
the EtOH group, and the EtOH + ZnPP-IX group, 
respectively. * p < 0.05, ** p < 0.001 
 
HO-1 inducer hemin reduced hepatic NOX1  
 
Immunoperoxidase staining for NOX1 and NOX4 
in rat hepatocytes at week 4 was illustrated in 
Figure 2 and Figure 3, respectively. The rats in 
the EtOH group and EtOH + ZnPP-IX group 
demonstrated a high number of immunopositive 
hepatocytes for NOX1 compared with the control 
group. The rats treated with HO-1 inducer hemin 
demonstrated a lower number of immunopositive 
hepatocytes for NOX1 compared to rats in the 
EtOH group and EtOH + ZnPP-IX group. In 
contrast, no difference in immunoreactivity for 





Figure 2: Immunoperoxidase staining for NOX1 in rat 
hepatocytes at week 4. (A) Rats in the control group. 
(B) Rats treated with ethanol. (C) Rats treated with an 
HO-1 inhibitor (ZnPP-IX) following ethanol gavage. (D) 
Rats treated with an HO-1 inducer (hemin) following 




Figure 3: Immunoperoxidase staining for NOX4 in rat 
hepatocytes at week 4. (A) Rats in the control group. 
(B) Rats treated with ethanol. (C) Rats treated with an 
HO-1 inhibitor (ZnPP-IX) following ethanol gavage. (D) 
Rats treated with an HO-1 inducer (hemin) following 
ethanol gavage. Scale bar = 20 µm 
 
As shown in Figure 4A, the percentage of 
positive stained hepatocytes for NOX1 was 
significant enhanced (p < 0.001) for the ethanol-
treated rats compared with rats in the control 
group. The rats treated with an HO-1 inhibitor 
(ZnPP-IX) following ethanol gavage had a 
significantly elevated (p < 0.001) percentage of 
positive stained hepatocytes compared with the 
ethanol-treated rats and rats in the control group. 
The rats treated with an HO-1 inducer (hemin) 
following ethanol gavage had a significantly 
decreased percentage of positive stained 
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hepatocytes compared with the ethanol-treated 
rats (p < 0.05) and HO-1 inhibitor-treated rats (p 
< 0.001). No difference in percentage of positive 
stained hepatocytes for NOX4 for male Wistar 





Figure 4: The percentage of positive stained 
hepatocytes for NOX1 (A) and NOX4 (B) at week 4 
(per group n = 6); a, b, c compared with control group, 
the EtOH group and the EtOH + ZnPP-IX group, 




The liver is a major target organ of alcohol-
induced injury. Oxidative stress is believed to 
involve liver damage induced by alcohol. 
Increased production of oxidants, including 
reactive oxygen species (ROS) and reactive 
nitrogen species (RNS) cause oxidative stress, 
which can damage cell components, including 
DNA, proteins and lipids [15]. Oxidation of 
ethanol leads to the pathology of liver disease, 
which comprises three major lesions and 
includes fatty liver, alcoholic hepatitis and 
cirrhosis, and eventually causes hepatocellular 
carcinoma. Research including in vitro, in vivo 
and clinical studies was investigated to 
understand the mechanism behind and develop 
a new approach to the management of alcohol-
induced liver disease. Recently, Palipoch et al 
demonstrated that ethanol treatment of male 
Wistar rats by gavage for 4 weeks can induce 
fatty liver, with elevated levels of oxidative stress 
biomarker. This indicates oxidative stress is an 
important mechanism in inducing alcohol-
induced liver injury [9]. 
 
Alcohol dehydrogenase (ADH) and cytochrome 
P450 2E1 (CYP2E1) are major pathways to 
oxidize ethanol to acetaldehyde. CYP2E1 is an 
effective generator of ROS [16]. Various 
endogenous sources such as inflammatory 
cells, respiratory chain, and nicotinamide 
adenine dinucleotide phosphate oxidase (NOX) 
can produce ROS [24]. Several types of NOX 
can be found in various cell types. NOX1 and 
NOX4 are the main ROS-producing NOX in 
hepatocytes [6]. A previous study demonstrated 
that CYP2E1 may play an important role in 
hepatocarcinogenesis induced by ethanol 
through causing oxidative stress to DNA,   while 
NOX can produce oxidants involved in 
developing liver injury induced by ethanol [17]. 
The results of the present study indicate that 
NOX gene expression was elevated in the 
ethanol-treated rats, similar to previous studies 
[18,19]. Moreover, NOX1 was increased in liver 
sections of ethanol-treated rats detected by 
immunohistochemistry. We suggest that NOX1 
is a key NOX that produces oxidants upon 
ethanol-induced liver injury. 
 
Normally, oxidants are cleared via an antioxidant 
defense mechanism. Inefficiency of the 
antioxidant defense system causes oxidative 
stress-induced pathologies. Current studies have 
shown increased interest in investigating 
effective exogenous antioxidants to ameliorate 
oxidative stress-related pathologies. Heme 
oxygenase (HO) is a critical stress-response 
protein that plays a key role in defense against 
oxidative stress [19-20]. Three different isoforms 
of mammalian HO have been reported, including 
inducible HO-1, constitutive HO-2, and HO-3, 
which is not catalytically active [15]. HO-1 (heat 
shock protein 32) plays a potential role in 
cytoprotective stress and acts as a defensive 
mechanism against oxidative stress. HO-1 
catalyzes the degradation of pro-oxidant heme to 
radical scavenging bile pigments, biliverdin, and 
bilirubin [22-24]. The present study demonstrates 
that an HO-1 inducer inhibits NOX gene 
expression and reduces NOX1 expression in 
liver sections. We suggest that an HO-1 inducer 
alleviates oxidative stress-induced alcoholic liver 




Oxidative stress is a major inducer of alcoholic 
liver injury through increased NOX gene 
expression and elevated expression of NOX1 in 
liver sections. An HO-1 inducer, hemin, alleviates 
Koomhin et al 
Trop J Pharm Res, May 2017; 16(5): 1043  
 
oxidative stress-induced alcoholic liver injury by 
reducing NOX, especially NOX1. Thus, hemin 
may be useful in developing an effective 
antioxidant supplementation to ameliorate 
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